https://dev.sparknewswire.com/newsfeed/hc-wainwright-co-reiterates-buy-on-oncternal-therapeutics-maintains-7-price-target/
HC Wainwright & Co. Reiterates Buy on Oncternal Therapeutics, Maintains $7 Price Target